What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibiotics
- Immune system
His scientific interests lie mostly in Immunology, Septic shock, Internal medicine, Microbiology and Shock.
Michel P. Glauser combines subjects such as Protease inhibitor and Nelfinavir with his study of Immunology.
He has researched Septic shock in several fields, including Respiratory disease and Acute respiratory distress.
His Internal medicine research integrates issues from Gastroenterology, Placebo and Surgery.
He has included themes like Lipopolysaccharide, Drug interaction and Pharmacology in his Microbiology study.
He interconnects Survival rate, Interleukin 6, Sepsis and Escherichia coli in the investigation of issues within Shock.
His most cited work include:
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli (919 citations)
- Protection from septic shock by neutralization of macrophage migration inhibitory factor. (699 citations)
- CD14 is a pattern recognition receptor. (628 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Immunology, Microbiology, Internal medicine, Antibiotics and Septic shock.
His Microbiology research is multidisciplinary, incorporating elements of Staphylococcus epidermidis, Endocarditis, Lipopolysaccharide, Vancomycin and Gram-negative bacteria.
His studies deal with areas such as Gastroenterology, Endocrinology and Surgery as well as Internal medicine.
The Antibiotics study combines topics in areas such as Clinical trial and Intensive care medicine.
His biological study deals with issues like Shock, which deal with fields such as Escherichia coli.
His Sepsis study combines topics from a wide range of disciplines, such as Antiserum and Intensive care.
He most often published in these fields:
- Immunology (33.65%)
- Microbiology (25.96%)
- Internal medicine (23.08%)
What were the highlights of his more recent work (between 2000-2021)?
- Immunology (33.65%)
- Intensive care medicine (16.35%)
- Innate immune system (8.65%)
In recent papers he was focusing on the following fields of study:
Michel P. Glauser mainly focuses on Immunology, Intensive care medicine, Innate immune system, Immune system and Clinical trial.
His study in Immunology focuses on Inflammation in particular.
His Inflammation study integrates concerns from other disciplines, such as Receptor, Septic shock, Sepsis and Disease.
His Intensive care medicine research includes elements of Fluconazole, Voriconazole, Aspergillosis and Antibiotics.
The study incorporates disciplines such as Macrophage and CD14 in addition to Innate immune system.
His study in Immune system is interdisciplinary in nature, drawing from both Macrophage migration inhibitory factor and Microbiology.
Between 2000 and 2021, his most popular works were:
- MIF regulates innate immune responses through modulation of Toll-like receptor 4 (497 citations)
- Antibiotics in sepsis (145 citations)
- Critical Role of Lipopolysaccharide-Binding Protein and CD14 in Immune Responses against Gram-Negative Bacteria (82 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Antibiotics
- Immune system
His main research concerns Intensive care medicine, Innate immune system, Immune system, Immunology and Antibiotics.
His work carried out in the field of Intensive care medicine brings together such families of science as Fluconazole, Neutropenia and Voriconazole.
His Innate immune system research is multidisciplinary, relying on both Cell activation, Macrophage migration inhibitory factor and Microbiology.
His biological study spans a wide range of topics, including Tumor necrosis factor alpha, Lipopolysaccharide binding protein, CD14, Gram-negative bacteria and Virulence.
His Antibiotics study combines topics in areas such as Itraconazole, Clinical trial, Critically ill and Chemotherapy.
Septic shock is the focus of his Sepsis research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
